Efficacy and Safety of Tenalisib in Patients With Metastatic Triple Negative Breast Cancer (TNBC)
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer (TNBC)
Interventions: DRUG: Tenalisib
Sponsor: Rhizen Pharmaceuticals SA
Collaborators: Incozen Therapeutics Pvt Ltd